Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1R76
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,521
Award facts
- Contract value 100% obligated
- $52,521.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) with a ceiling value of $52,521.13. This firm fixed-price delivery order, with an ultimate completion date of December 30, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a selective Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military healthcare systems.
This delivery order is a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements and serve as a reliable supplier for the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F1R76?
SPE2DR26F1R76 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F1R76 worth?
The government has obligated $52,521 on SPE2DR26F1R76.
Is contract SPE2DR26F1R76 an order under another contract?
Yes. SPE2DR26F1R76 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1R76 competed?
The extent of competition for SPE2DR26F1R76 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award